Literature DB >> 2926793

Recovery of spores of Clostridium difficile altered by heat or alkali.

S Kamiya1, K Yamakawa, H Ogura, S Nakamura.   

Abstract

The effect of heating or alkali-treatment on spore recovery in ordinary growth medium was examined for four strains of Clostridium difficile. Heating spores at 80 degrees C for 10 min produced 95.50-99.95% decreases in the recovery rates. Treatment with 0.1 N NaOH for 15 min produced 99.47 and 99.83% decreases in spore recovery rates for two of the four strains. The influence of either addition of lysozyme after treatment with sodium thioglycollate (thioglycollate-lysozyme method) or addition of sodium taurocholate (taurocholate method) on recovery of heat- or alkali-treated C. difficile spores was also examined. Viable spores of all strains altered by heating at 90 degrees C or 100 degrees C for 10 min could not be recovered at all by the taurocholate method. Nor did this method allow recovery of alkali-altered spores treated with greater than 0.2 N NaOH for 15 min. On the other hand, 10-47% of altered spores heated at 90 degrees C for 10 min were recovered by the thioglycollate-lysozyme method, and alkali-altered spores treated with 0.1-0.3 N NaOH for 15 min were as completely recovered by this method as untreated spores. These results indicate that the thioglycollate-lysozyme method is more effective than the taurocholate method for recovery of the heat- or alkali-altered C. difficile spores.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926793     DOI: 10.1099/00222615-28-3-217

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

Review 2.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

Review 3.  A possible route for foodborne transmission of Clostridium difficile?

Authors:  Barbara M Lund; Michael W Peck
Journal:  Foodborne Pathog Dis       Date:  2015-01-19       Impact factor: 3.171

Review 4.  Updates to Clostridium difficile Spore Germination.

Authors:  Travis J Kochan; Matthew H Foley; Michelle S Shoshiev; Madeline J Somers; Paul E Carlson; Philip C Hanna
Journal:  J Bacteriol       Date:  2018-07-25       Impact factor: 3.490

5.  Comparison of five cultural procedures for isolation of Clostridium difficile from stools.

Authors:  L M Marler; J A Siders; L C Wolters; Y Pettigrew; B L Skitt; S D Allen
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

6.  Clostridium difficile infection: a critical overview.

Authors:  Bayan Missaghi; August J Valenti; Robert C Owens
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

7.  Bile salts and glycine as cogerminants for Clostridium difficile spores.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2008-02-01       Impact factor: 3.490

8.  Susceptibility of hamsters to Clostridium difficile isolates of differing toxinotype.

Authors:  Anthony M Buckley; Janice Spencer; Lindsay M Maclellan; Denise Candlish; June J Irvine; Gillian R Douce
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection.

Authors:  Michael B Francis; Charlotte A Allen; Ritu Shrestha; Joseph A Sorg
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

10.  Identification of a Novel Lipoprotein Regulator of Clostridium difficile Spore Germination.

Authors:  Kelly A Fimlaid; Owen Jensen; M Lauren Donnelly; Michael B Francis; Joseph A Sorg; Aimee Shen
Journal:  PLoS Pathog       Date:  2015-10-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.